학술논문
Phase I study of rapid alternation of sunitinib and regorafenib for the treatment of tyrosine kinase inhibitor refractory gastrointestinal stromal tumors
Document Type
Article
Author
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 15 December 2019, 25(24):7287-7293)
Subject
Language
English
ISSN
15573265
10780432
10780432